Description: Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.
Home Page: www.novozymes.com
Krogshoejvej 36
Bagsvaerd,
2880
Denmark
Phone:
45 44 46 00 00
Officers
| Name | Title |
|---|---|
| Ms. Ester Baiget | Pres & CEO |
| Mr. Lars Green M.Sc., MSc | Exec. VP & CFO |
| Ms. Graziela Chaluppe dos Santos Malucelli | COO and Exec. VP of Operations, Supply & Quality |
| Mr. Tobias Cornelius Bjorklund | Head of Investor Relations |
| Mr. Tue Micheelsen | VP of Global Sales & Marketing |
| Mr. Morten Enggaard Rasmussen | Exec. VP of People, Sustainability & Brand |
| Mr. Pedro Luiz Fernandes | Head of Corp. Affairs & Sustainability - Novozymes Latin America |
| Mr. Anders Lund | Exec. VP of Consumer Biosolutions |
| Mr. Sebastian Søderberg | VP and Head of New Bus. Devel. - Incubations & Acquisitions |
| Ms. Tina Sejersgaard Fanoe | Exec. VP of Agriculture & Industrial Biosolutions |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 29.3255 |
|---|---|
| Trailing PE: | 29.6857 |
| Price-to-Book MRQ: | 6.1231 |
| Price-to-Sales TTM: | 0.8047 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 6741 |